U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Quotables

"The production of too many useful things results in too many useless people."

Karl Marx

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 546/310 - Having -C(=X)-, wherein X is chalcogen, bonded directly to the six-membered hetero ring


Subclass of Class 546 - Organic compounds -- part of the class 532-570 series
Definition: Compounds wherein a group, in which X is chalcogen (i.e.,
No. of patents: 205
Last issue date: 10/11/2011


1            
NumberTitleIssue Date
8034950Processes for the facile synthesis of diaryl amines and analogues thereof
The present invention relates to processes for the facile synthesis of diaryl amines and analogues thereof. The processes of the present invention produce diaryl amines in high yield and purity. The present invention also relates to intermediates useful in the proce...
10/11/2011
79561913-arylamino pyridine derivatives
The invention provides novel, substituted 3-arylamino pyridine compounds (I) pharmaceutically acceptable salts, solvates and prodrug compounds thereof, wherein W, R1, R2, R9, R10, R11, R12, R13, R14 are as defined in the specification. Such compounds are MEK inhibit...
06/07/2011
7435743Pyridine derivatives
Pyrimidine compounds of general formula: wherein —R1 represents in which R11 is hydrogen, C1-6 alkyl, halogen, hydroxy, C1-12 alkoxy,...
10/14/2008
74322895-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors
Compounds of formula (I): or pharmaceutically acceptable salts or solvates thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors. ...
10/07/2008
73421153-substituted-6-aryl pyridines
3-substituted-6-aryl pyridines of Formula I are provided: wherein R1, R2, R3, R8, R9, A and Ar are defined herein. Such compounds are ligands of C5a receptor. Preferred...
03/11/2008
7320993Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic useful as cytostatic and immuosuppressive agents
The invention relates to new pyridylalkane, alkene, and alkine acid amides substituted with an aryl and/or heteroaryl residue according to the general formula (I), with a saturated or one or several-fold unsaturated hydrocarbon residue in the carboxylic acid group, ...
01/22/2008
7282583Process for making 5,11-Dihydro-11-ethyl-5-methyl-8{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-di pyrido[3,2-b:2′,3′-e][1,4]diazepin-6-one
An improved process for making 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-di pyrido[3,2-b:2′,3′-e][1,4]diazepin-6-one. ...
10/16/2007
7232926Method for the production of sulphamic acid halogenides
The present invention relates to a process for preparing sulfamoyl halides of primary or secondary amines, comprising the following steps: i) reacting a primary or secondary amine A1 with at least equimolar amounts of SO3
06/19/2007
7223868Heteroaromatic glucokinase activators
2,3-Di-substituted N-heteroaromatic propionamides with said substitution at the 3-position being a substituted phenyl group and at the 2-position being a methyl cycloalkyl ring, said propionamides being glucokinase activators which increase insulin secretion in the ...
05/29/2007
7157583Process for producing high-purity 2,3-pyridinedicarboxylic acid
A process for producing 2,3-pyridinedicarboxylic acid having a significantly decreased heavy metal content and capable of satisfying the purity level required for medicinal and agricultural chemicals comprising the steps of: adding at least one sulfur-containing sub...
01/02/2007
7115746Processes for the facile synthesis of diaryl amines and analogues thereof
The present invention relates to processes for the facile synthesis of diaryl amines and analogues thereof. The processes of the present invention produce diaryl amines in high yield and purity. The present invention also relates to intermediates useful in the proce...
10/03/2006
6987199Process for preparing beta-ketoester compound
The present invention relates to a new process for preparing beta-ketoester compound of the following formula (1), which is a useful intermediate for the synthesis of such quinoline antibiotics as Ciprofloxacin, Levofloxacin, Gemifloxacin, Trovafloxacin, etc. The qu...
01/17/2006
6962994Process for the synthesis of 1,3-diols
An improved process for the preparation of cis-1,3-diols is described where a beta hydroxy ketone is treated with a trialkylborane or dialkylalkoxyborane or a mixture of a trialkylborane and a dialkylalkoxyborane followed by recovery and reuse of the alkylborane spe...
11/08/2005
6949556Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical agents
The present invention relates to compounds of general formula (I), wherein R1-R4 have the meanings given in the specification, A is CH2, CHOH or CH—(C1-C3-alkyl), B and C a...
09/27/2005
6919336Hallogenated aminobenzophenones and aminobenzoylpyridines as inhibitors of IL-1 and TNF
Compounds of formula I and pharmaceutically-acceptable and -cleavable esters thereof and acid addition salts thereof wherein the symbols are as defined are MAP kinase inhibitors, useful pharmaceutically for treating TNFα and IL-1 mediated diseases such as rheumatoi...
07/19/2005
6914160Oxytocin inhibitors
This invention relates to compounds of formula (I) ...
07/05/2005
6825221Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
According to the invention there is provided a compound the formula I; wherein A, X, B, R1, R2, R3 and R4 are as defined in the specification. ...
11/30/2004
6800650Pyridine and quinoline derivatives
The present invention provides compounds of formula (I) wherein R1, R2, R3 and R4 are as defined in the specification, and pharmaceutically acceptable salts thereof. The compou...
10/05/2004
6794397Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
The present invention is directed to substituted nicotinamides and analogs thereof, represented by Formula V: or a pharmaceutically acceptable salt or prodrug thereof, wherein: Ar′ and Ar are independently optio...
09/21/2004
67502322-aminopyridine compounds and use thereof as drugs
A class of substituted compounds is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by formula (II), wherein R1 is selected from hydrido, halo, alkoxy, aryl, alkylthio, alkylamino...
06/15/2004
6680383Method for making nevirapine
A process for making nevirapine, comprising the following steps: (a) reacting a 2-halo-3-pyridinecarbonitrile of the formula ##STR1## wherein X is a fluorine, chlorine, bromine or iodine atom, preferably chlorine or bromine, with cyclopropylamine, to y...
01/20/2004
6632823Substituted pyridine compounds useful as modulators of acetylcholine receptors
In accordance with the present invention, a novel class of substituted pyridine compounds (optionally containing ether, ester, amide, ketone or thioether substitutions) that promote the release of ligands involved in neurotransmission have been discovered...
10/14/2003
64204381-amino-7-isoquinoline derivatives as serine protease inhibitors
The invention relates to serine protease inhibitor compounds of formula (I) ##STR1## where R1 is hydrogen, halo, cyano, nitro or hydroxyl, amino, alkoxy, alkyl, aminoalkyl, hydroxyalkyl, thiol, alkylthio, aminosulphonyl, alkoxyalkyl, alkoxycarb...
07/16/2002
6365603Aromatic compounds and pharmaceutical compositions containing them
Compounds of formula I useful for inhibiting the pain enhancing effects of E-type prostaglandins are disclosed ##STR1## wherein A is a ring system in which the --CH(R.sup.3)N(R.sup.2)B--R.sup.1 and --OR.sup.4 groups are positioned in a 1,2 relationship to...
04/02/2002
6362009Solid phase synthesis of heterocycles
Methods for solid phase and combinatorial synthesis using a resin activation/capture approach are provided. In particular, methods for the production of dihydropyridones, N-acyidihydropyridones, tetrahydropyridones, pyridines, aminopyridines, N-acyltetrah...
03/26/2002
6350762Dihydropyridine derivative
Dihydropyridine derivatives of the following formula, analogs thereof and pharmaceutically acceptable salts thereof have an activity of selectively inhibiting the action of N-type calcium channel. They are used as remedies for various diseases relating to...
02/26/2002
6316503LXR modulators
The invention provides compounds, compositions and methods for modulating the effects of LXR in a cell. The compounds and compositions are useful both as diagnostic indicators of LXR function and as pharmacologically active agents. The compounds and compo...
11/13/2001
6313302Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
A compound of the following formula: ##STR1## and the salts thereof, wherein A is hydrogen, halo, or hydroxy; the broken line represents an optional double bond with proviso that if the broken line is a double bond, then A is absent; Ar1 is opt...
11/06/2001
6313148Aromatic amine compounds that antagnoize the pain enhancing effects of prostaglandins
Compounds antagonistic of the pain enhancing effects of prostaglandins are disclosed. The compounds comprise an optionally-substituted A ring with a --CH(R3)N(R2)B--R1 and --OD groups positioned in a 1,2 relationship to on...
11/06/2001
6197795Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
The present invention relates to the discovery of novel, low molecular weight, non-peptide inhibitors of matrix metalloproteinases (e.g. gelatinases, stromelysins and collagenases) and TNF-଱ converting enzyme (TACE, tumor necrosis factor-଱ con...
03/06/2001
6127392Anthranilic acid analogs
Compounds of the formula: wherein: R1, R2, R3, R4,R5, R6, R7 and R8 are, independently, hydrogen, COOR15, halogen, nitro, cyano, C1-10 alkoxy, C1...
10/03/2000
6124457Process and intermediates for a ଲ3 -adrenergic receptor agonist
The instant invention relates to intermediates of Formula II, ##STR1## wherein R1, R2 and R3 are as defined in the specification, and to processes for preparing such intermediates. This invention also relates to proce...
09/26/2000
6121454Synthesis of pharmaceutically useful pyridine derivatives
A process is provided for the preparation of compounds of formula I, ##STR1## useful in the preparation of compounds such as Omeprazole, Lansoprazole and Pantoprazole, wherein R1 =H or CH3, R2 =H or CH3, R
09/19/2000
6034244Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity
Compounds of the formula ##STR1## wherein the symbols have the meaning defined in the specification, have retinoid-like biological activity....
03/07/2000
6015569Polycyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
Novel pharmaceutically/cosmetically-active polycyclic aromatic compounds have the structural formula (I): ##STR1## wherein Ar is a radical having one of the formulae (a)-(e): ##STR2## and are useful for the treatment of a wide variety of disease...
01/18/2000
6002012Process for the preparation of [(5,6-dicarboxy-3-pyridyl) methyl] ammonium halides
There is provided a process for the preparation of [(5,6-dicarboxy-3-pyridyl)methyl]ammonium halides having the structural formula I ##STR1## The [(5,6-dicarboxy-3-pyridyl)methyl]ammonium halides are useful as intermediates in the preparation of...
12/14/1999
5965735Process for preparing flunixin and intermediates thereof
Process for preparing a key intermediate, 2-methyl-3-trifluoromethylaniline (MTA) of Flunixin, as well as novel intermediates thereof are described....
10/12/1999
5962481Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
The present invention relates to the discovery of novel, low molecular weight, non-peptide inhibitors of matrix metalloproteinases (e.g. gelatinases, stromelysins and collagenases) and TNF-଱ converting enzyme (TACE, tumor necrosis factor-଱ con...
10/05/1999
5959116Pyridine-2, 3-dicarboximides their preparation and their use for controlling undesired plant growth
A pyridine-2,3-dicarboxylic acid diester of the formula Va ##STR1## where the radicals R2 and R4 have the meanings set out in the specification and where R8 is a C1 -C4 -alkyl, C3 -C
09/28/1999
5929098Fungicidically active N-acetonylbenzamide compounds
Novel N-acetonylbenzamides are disclosed. These compounds are useful in controlling phytopathogenic fungi....
07/27/1999
1            
 
Sign InRegister
Username  
Password   
forgot password?